Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immune system
Biotech
Lilly joins platform biotech's Repertoire with $1.9B deal
With three Big Pharma collaborations already under its belt, Repertoire Immune Medicines just picked up its biggest R&D deal yet.
Fraiser Kansteiner
Jan 29, 2026 6:30am
Veteran venture capitalists launch autoimmune firm Vie Ventures
Jul 9, 2025 11:10am
GSK and Cambridge scientists join forces in $65M immune R&D deal
Oct 22, 2024 3:30pm
BMS pays $65M to expand Repertoire of autoimmune assets
Apr 29, 2024 6:15am
New cell discovery could repair damaged salivary and tear glands
Apr 18, 2022 8:25am
Adaptive Biotechnologies lays off 12% of workforce
Mar 9, 2022 12:02pm
